Company: SXTPW
Filing Date: 2025-09-05
Form Type: 424B5
Source: 0001213900-25-085050
Chunk: 98

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-09-05
Form: 424B5
Chunk 98
---
 any securities.

<div align='center'>LEGAL MATTERS</div>

Unless otherwise indicated in the applicable prospectus
supplement, the validity of the issuance of the securities offered hereby will be passed upon for us by Sichenzia Ross Ference Carmel
LLP located in New York, New York. Additional legal matters may be passed upon for us or any underwriters, dealers or agents, by counsel
that we will name in the applicable prospectus supplement.

<div align='center'>EXPERTS</div>

RBSM LLP, an independent registered public accounting
firm, audited our financial statements for the years ended December 31, 2023 and 2022, respectively. We have included our financial statements
in this prospectus and elsewhere in the registration statement in reliance on the reports of RBSM LLP, given their authority as experts
in accounting and auditing.

<div align='center'>WHERE YOU CAN FIND MORE INFORMATION</div>

This prospectus is part of the registration statement
on Form S-3 that we filed with the Commission under the Securities Act and does not contain all of the information set forth in the
registration statement. Whenever a reference is made in this prospectus to any of our contracts, agreements or other documents, the reference
may not be complete and you should refer to the exhibits that are part of the registration statement or the exhibits to the reports or
other document incorporated into this prospectus for a copy of such contract agreement or other document. Because we are subject to the
information and reporting requirements under the Exchange Act, we file annual, quarterly and current reports, proxy statements and other
information with the Commission. Our filings with the Commission are available to the public over the Commission’s website at www.sec.gov.
Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including any amendments to those reports,
and other information that we file with or furnish to the Commission pursuant to Section 13(a) or 15(d) of the Exchange Act can also be
accessed free of charge on our website. You may also read and copy any document we file with the SEC at its public reference facility
at 100 F Street, N.E., Washington, D.C., 20549, on official business days during the hours of 10 a.m. to 3 p.m. You may also obtain copies
of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 100